About this trial
Post-market, observational study to assess effectiveness of TissuePatch SF in managing/preventing air leaks after lung resection.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Is ≥18 and <80 years of age
Undergoing planned (not emergent) video-assisted thoracic surgery pulmonary resection
Understands and is willing to comply with all study related procedures
Has provided signed informed consent
Disqualifiers
Women who are pregnant or lactating or, if of childbearing potential, are unwilling to use birth control for 6-months following surgery
Has severe congestive heart failure, pulmonary or renal failure, serious haematological disorder or significant liver disease
Has previously undergone a pneumonectomy
Has a bronchial fistula
Trial population
Patients undergoing lung resection
Trial design
Cohort
Prospective
Treatments tested in this trial
TissuePatch Sealant Film
DeviceSealant film
Treatment groups
Trial outcomes
Primary outcomes
Intra-operative air leaks
Air leaks successfully sealed or reduced as assessed by a submersion air leak test
Secondary outcomes
Overall device safety
Incidence of serious adverse events
Overall device safety
Adverse events probably or causally related to the study device
Locations
This trial is not recruiting at the moment. You can still explore other options: